A Heavy Heart: The FDA Weighs CV Side Effects

Published on Wednesday 19 November 2008 - 12:57

Summary :
The rise of serious heart risks in drugs that treat chronic conditions has become one of the FDA s top worries and is changing how the agency weighs new meds, according to John Jenkins, director of...
Read more

Information source

Pharmalot

http://www.pharmalot.com

Website description
News, Comment and Conversation

Articles published on this website : 0 / 7 days - 10 / 30 days

Older Americans Use Risky Drug Combinations Lowering Co-Pays May Not Boost Compliance For Some Drugmakers, The World Will Be Flat The Vytorin Limbo: Prescriptions Decline Again Glaxo Places Big Bet On Drug For Clogged

Other articles published on other websites on the same day

GOING NUTTY http://www.todayonline.com/ ORIGINAL ARTICLE: Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein http://content.nejm.org/ Healthwatch for Nov. 19, 2008 http://www.statejournal.com/ Statins For All? Not So Fast, Expert Says http://www.wxii12.com/ FDA to examine CV side effects of several meds http://www.fiercepharma.com/ Convergence08 http://nextbigfuture.com/ Mind Reader http://www.portfolio.com/ Drugs may Delay artery Damage in Children http://tomsrivertimes.micromediapubs.com/ New possibilites for next fall screenings at Loan Closet http://www.hsvvoice.com/ Nine Spanish Wineries Present an R&D Project to Increase the Beneficial Effects of Wine on Health http://www.newswiretoday.com/